Aoxing medical (688613.SH) plans to distribute a dividend of 0.06 yuan per share in 2023, with ex-rights and ex-dividend on July 9th.

Ojion Medical (688613.SH) announced that the company plans to distribute a cash dividend of 0.06001 yuan per share (including tax) for the year 2023, with the record date on July 8, 2024 and the ex-dividend date on July 9, 2024.

Zhitong FinanceJul 1 04:50 ET

Zhitong A Share Sale Restriction and Release List | May 21

According to the Zhitong Finance App, the ban on restricted shares of 4 listed companies was lifted on May 21, with a total market value of about 587 million yuan. Today's specific sales restrictions and unbanned stocks are as follows: Stock abbreviation, stock code, restricted stock type, number of shares unbanned, Jinzai Foods 003000, share incentives, limited sales and circulation 1615, Wanzhi, smart, 001339, share incentives, 6576, 10,000 Aojing Medical, 6886132.80741 million, Wanrun Xinneng, 68,2752.24 million

Zhitong FinanceMay 20 21:00 ET

Aojing Healthcare (688613.SH): The ban on 2.80741 million restricted shares was lifted on May 21

Gelonghui, May 13 | Aojing Medical (688613.SH) announced that the total number of shares in circulation in the company's current stock listing was 28.741 million shares. The stock listing and circulation date is May 21, 2024.

Gelonghui FinanceMay 13 06:27 ET

Allgens Medical Technology (SHSE:688613) Posted Weak Earnings But There Is More To Worry About

The market shrugged off Allgens Medical Technology CO., LTD.'s (SHSE:688613) weak earnings report. Despite the market responding positively, we think that there are several concerning factors that in

Simply Wall StMay 2 18:56 ET

Aojing Medical (688613.SH) announced its 2023 annual results. Net profit of 54.3218 million yuan decreased by 43.04% year on year

Aojing Medical (688613.SH) released its 2023 annual performance report. The company achieved operating revenue during the reporting period...

Zhitong FinanceApr 25 05:12 ET

Aojing Healthcare (688613.SH) performance report: 2023 net profit of 53.9018 million yuan, a year-on-year decrease of 43.39%

Gelonghui, Feb. 27丨Aojing Medical (688613.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved total operating revenue of 226 million yuan, a year-on-year decrease of 7.68%; net profit attributable to owners of the parent company was 53.9018 million yuan, a year-on-year decrease of 43.39%.

Gelonghui FinanceFeb 27 05:05 ET